 Amryt Pharma PLC has completed its acquisition of US group Chiasma Inc with Raj Kannan and Roni Mamluk joining the board as non-executive directors. Joe Wiley, Amryts chief executive, said: This transaction further solidifies our position as a global leader in treating rare and orphan conditions. 